Sector valuations Bolt Biotherapeutics, Inc.
Equities
BOLT
US0977022039
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.390 USD | +8.02% |
|
+13.71% | -1.43% |
| 03-12 | Bolt Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 03-11 | Bolt Biotherapeutics, Inc. Auditor Raises 'Going Concern' Doubt | CI |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -0.26x | - | -0.04x | - | - | - | - | 9.59M | ||
| 28.36x | 5.53x | 0.62x | 7.48x | 22.28x | 23.46x | 0.05% | 50.17B | ||
| 16.9x | 3.12x | -1.43x | 5.07x | 11.51x | 13.36x | 1.75% | 43.62B | ||
| -54.72x | 63.28x | 0.91x | 17.39x | -58.82x | -59.75x | -.--% | 30.43B | ||
| -20.9x | 1.26x | 6.27x | 5.55x | -10.88x | -8.44x | -.--% | 28.22B | ||
| -21.2x | 101.19x | 1.56x | 2544.1x | -29.53x | -20.6x | -.--% | 20.45B | ||
| 28.04x | 2.64x | 0.69x | 5.48x | 15.23x | 19x | -.--% | 18.65B | ||
| -444.22x | 14.75x | 8.53x | 34.97x | 4390.34x | -421.28x | -.--% | 17.26B | ||
| 22.63x | 2.45x | -1.07x | 3.91x | 11.97x | 14.47x | -.--% | 16.71B | ||
| -503.17x | 20.63x | 10.63x | 36.35x | -2284.69x | -359.1x | -.--% | 14.9B | ||
| -110.84x | 19.05x | 1.76x | 7.77x | -219.02x | -85.01x | -.--% | 12.11B | ||
| 15.01x | 3.87x | 1.51x | 4.12x | 9.76x | 11.01x | -.--% | 11.66B | ||
| 15.79x | 8.06x | 0.04x | 9.53x | 15.89x | 15.6x | -.--% | 10.44B | ||
| 34.54x | 5.64x | -2.76x | 7.79x | 30.32x | 34.59x | - | 9.64B | ||
| -20.56x | 40.83x | -0x | 21.56x | -24.42x | -19.96x | -.--% | 9.95B | ||
| -8.2x | - | -0.26x | - | -7.28x | -7.06x | -.--% | 8.71B | ||
| -18.85x | 8.33x | 6.65x | 547.24x | -16.15x | -16.56x | -.--% | 8.42B | ||
| -31.4x | - | 0.98x | - | - | - | - | 8.37B | ||
| -10.12x | -17.91x | 18.99x | 85.19x | -10.79x | -10.43x | -.--% | 8.1B | ||
| Average | -57.01x | 17.67x | 2.82x | 208.97x | 108.57x | -51.57x | 0.11% | 17.25B | |
| Weighted average by Cap. | -49.54x | 18.80x | 2.24x | 194.57x | 120.54x | -42.67x | 0.25% |
- Stock Market
- Equities
- BOLT Stock
- Sector Bolt Biotherapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















